This article is more than 5 years old. Information may no longer be current.
Artiflex phakic IOL receives CE mark
Click Here to Manage Email Alerts
GRONINGEN, Netherlands — A foldable phakic IOL for the treatment of myopia has been granted the CE Mark in Europe, lens maker Ophtec said in a press release.
The Artiflex is a foldable version of the company’s Artisan phakic IOL (marketed by Advanced Medical Optics as the Verisyse in the United States and other markets).
“The significant benefit of the Artiflex is that it can be inserted through a minimally invasive microincision, therefore dramatically reducing recovery time and increasing patient satisfaction,” according to Ophtec.
Erik Jan Worst, MD, president and chief executive officer of Ophtec, said surgeons involved in the clinical trial of the Artiflex “were amazed by the results and quick visual recovery.”
The new lens will be available immediately in Europe to surgeons who have completed a specialized training course, the press release said.